img

Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Extreme Lateral Interbody Fusion (XLIF) Surgery Market
Global Extreme Lateral Interbody Fusion (XLIF) Surgery market is expected to reach to US$ 1043 million in 2023, with a positive growth of %, compared with US$ 1000 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Extreme Lateral Interbody Fusion (XLIF) Surgery industry is evaluated to reach US$ 1342.7 million in 2033. The CAGR will be 4.3% during 2023 to 2033.
Globally, Extreme Lateral Interbody Fusion (XLIF) Surgery key companies include Medtronic Plc, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc., NuVasive Inc., Globus Medical Inc., DePuy Synthes, B. Braun Melsungen AG and Alphatec Holdings Inc., etc. Medtronic Plc, Johnson & Johnson, Stryker Corporation are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Extreme Lateral Interbody Fusion (XLIF) Surgery were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Extreme Lateral Interbody Fusion (XLIF) Surgery market and estimated to attract more attentions from industry insiders and investors.
Extreme Lateral Interbody Fusion (XLIF) Surgery can be divided into XLIF Interbody Fusion Systems and XLIF Interbody Cages, etc. XLIF Interbody Fusion Systems is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Extreme Lateral Interbody Fusion (XLIF) Surgery is widely used in various fields, such as Spinal Surgery Centers, Hospitals and Others,, etc. Spinal Surgery Centers provides greatest supports to the Extreme Lateral Interbody Fusion (XLIF) Surgery industry development. In 2022, global % revenue of Extreme Lateral Interbody Fusion (XLIF) Surgery went into Spinal Surgery Centers filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Extreme Lateral Interbody Fusion (XLIF) Surgery market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Extreme Lateral Interbody Fusion (XLIF) Surgery market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Medtronic Plc
Johnson & Johnson
Stryker Corporation
Zimmer Biomet Holdings Inc.
NuVasive Inc.
Globus Medical Inc.
DePuy Synthes
B. Braun Melsungen AG
Alphatec Holdings Inc.
RTI Surgical Holdings Inc.
K2M Group Holdings Inc.
Orthofix Medical Inc.
Aesculap Implant Systems
SpineWave Inc.
MicroPort Scientific Corporation
Life Spine Inc.
Captiva Spine Inc.
CoreLink Surgical LLC
CTL Medical Corporation
Providence Medical Technology Inc.
Safe Orthopaedics
Spinal Elements Holdings Inc.
Spineology Inc.
Wenzel Spine Inc.
Xenco Medical.
Segment by Type
XLIF Interbody Fusion Systems
XLIF Interbody Cages

Segment by Application


Spinal Surgery Centers
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Extreme Lateral Interbody Fusion (XLIF) Surgery introduction, etc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Extreme Lateral Interbody Fusion (XLIF) Surgery
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 XLIF Interbody Fusion Systems
1.2.3 XLIF Interbody Cages
1.3 Market by Application
1.3.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Spinal Surgery Centers
1.3.3 Hospitals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Perspective (2018-2033)
2.2 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Growth Trends by Region
2.2.1 Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Extreme Lateral Interbody Fusion (XLIF) Surgery Historic Market Size by Region (2018-2023)
2.2.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Forecasted Market Size by Region (2024-2033)
2.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Market Dynamics
2.3.1 Extreme Lateral Interbody Fusion (XLIF) Surgery Industry Trends
2.3.2 Extreme Lateral Interbody Fusion (XLIF) Surgery Market Drivers
2.3.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Market Challenges
2.3.4 Extreme Lateral Interbody Fusion (XLIF) Surgery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Extreme Lateral Interbody Fusion (XLIF) Surgery by Players
3.1.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Players (2018-2023)
3.1.2 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Players (2018-2023)
3.2 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Extreme Lateral Interbody Fusion (XLIF) Surgery, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Concentration Ratio
3.4.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in 2022
3.5 Global Key Players of Extreme Lateral Interbody Fusion (XLIF) Surgery Head office and Area Served
3.6 Global Key Players of Extreme Lateral Interbody Fusion (XLIF) Surgery, Product and Application
3.7 Global Key Players of Extreme Lateral Interbody Fusion (XLIF) Surgery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Extreme Lateral Interbody Fusion (XLIF) Surgery Breakdown Data by Type
4.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Historic Market Size by Type (2018-2023)
4.2 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Forecasted Market Size by Type (2024-2033)
5 Extreme Lateral Interbody Fusion (XLIF) Surgery Breakdown Data by Application
5.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Historic Market Size by Application (2018-2023)
5.2 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2033)
6.2 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type
6.2.1 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023)
6.2.2 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2033)
6.2.3 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Type (2018-2033)
6.3 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application
6.3.1 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023)
6.3.2 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2033)
6.3.3 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Application (2018-2033)
6.4 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country
6.4.1 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023)
6.4.3 North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2033)
7.2 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type
7.2.1 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023)
7.2.2 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2033)
7.2.3 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Type (2018-2033)
7.3 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application
7.3.1 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023)
7.3.2 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2033)
7.3.3 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Application (2018-2033)
7.4 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country
7.4.1 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023)
7.4.3 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2033)
8.2 China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type
8.2.1 China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023)
8.2.2 China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2033)
8.2.3 China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Type (2018-2033)
8.3 China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application
8.3.1 China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023)
8.3.2 China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2033)
8.3.3 China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2033)
9.2 Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type
9.2.1 Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023)
9.2.2 Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2033)
9.2.3 Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Type (2018-2033)
9.3 Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application
9.3.1 Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023)
9.3.2 Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2033)
9.3.3 Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Application (2018-2033)
9.4 Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region
9.4.1 Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region (2018-2023)
9.4.3 Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type
10.2.1 Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application
10.3.1 Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country
10.4.1 Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Medtronic Plc
11.1.1 Medtronic Plc Company Details
11.1.2 Medtronic Plc Business Overview
11.1.3 Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.1.4 Medtronic Plc Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.1.5 Medtronic Plc Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.2.4 Johnson & Johnson Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.2.5 Johnson & Johnson Recent Developments
11.3 Stryker Corporation
11.3.1 Stryker Corporation Company Details
11.3.2 Stryker Corporation Business Overview
11.3.3 Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.3.4 Stryker Corporation Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.3.5 Stryker Corporation Recent Developments
11.4 Zimmer Biomet Holdings Inc.
11.4.1 Zimmer Biomet Holdings Inc. Company Details
11.4.2 Zimmer Biomet Holdings Inc. Business Overview
11.4.3 Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.4.4 Zimmer Biomet Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.4.5 Zimmer Biomet Holdings Inc. Recent Developments
11.5 NuVasive Inc.
11.5.1 NuVasive Inc. Company Details
11.5.2 NuVasive Inc. Business Overview
11.5.3 NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.5.4 NuVasive Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.5.5 NuVasive Inc. Recent Developments
11.6 Globus Medical Inc.
11.6.1 Globus Medical Inc. Company Details
11.6.2 Globus Medical Inc. Business Overview
11.6.3 Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.6.4 Globus Medical Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.6.5 Globus Medical Inc. Recent Developments
11.7 DePuy Synthes
11.7.1 DePuy Synthes Company Details
11.7.2 DePuy Synthes Business Overview
11.7.3 DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.7.4 DePuy Synthes Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.7.5 DePuy Synthes Recent Developments
11.8 B. Braun Melsungen AG
11.8.1 B. Braun Melsungen AG Company Details
11.8.2 B. Braun Melsungen AG Business Overview
11.8.3 B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.8.4 B. Braun Melsungen AG Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.8.5 B. Braun Melsungen AG Recent Developments
11.9 Alphatec Holdings Inc.
11.9.1 Alphatec Holdings Inc. Company Details
11.9.2 Alphatec Holdings Inc. Business Overview
11.9.3 Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.9.4 Alphatec Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.9.5 Alphatec Holdings Inc. Recent Developments
11.10 RTI Surgical Holdings Inc.
11.10.1 RTI Surgical Holdings Inc. Company Details
11.10.2 RTI Surgical Holdings Inc. Business Overview
11.10.3 RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.10.4 RTI Surgical Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.10.5 RTI Surgical Holdings Inc. Recent Developments
11.11 K2M Group Holdings Inc.
11.11.1 K2M Group Holdings Inc. Company Details
11.11.2 K2M Group Holdings Inc. Business Overview
11.11.3 K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.11.4 K2M Group Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.11.5 K2M Group Holdings Inc. Recent Developments
11.12 Orthofix Medical Inc.
11.12.1 Orthofix Medical Inc. Company Details
11.12.2 Orthofix Medical Inc. Business Overview
11.12.3 Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.12.4 Orthofix Medical Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.12.5 Orthofix Medical Inc. Recent Developments
11.13 Aesculap Implant Systems
11.13.1 Aesculap Implant Systems Company Details
11.13.2 Aesculap Implant Systems Business Overview
11.13.3 Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.13.4 Aesculap Implant Systems Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.13.5 Aesculap Implant Systems Recent Developments
11.14 SpineWave Inc.
11.14.1 SpineWave Inc. Company Details
11.14.2 SpineWave Inc. Business Overview
11.14.3 SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.14.4 SpineWave Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.14.5 SpineWave Inc. Recent Developments
11.15 MicroPort Scientific Corporation
11.15.1 MicroPort Scientific Corporation Company Details
11.15.2 MicroPort Scientific Corporation Business Overview
11.15.3 MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.15.4 MicroPort Scientific Corporation Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.15.5 MicroPort Scientific Corporation Recent Developments
11.16 Life Spine Inc.
11.16.1 Life Spine Inc. Company Details
11.16.2 Life Spine Inc. Business Overview
11.16.3 Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.16.4 Life Spine Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.16.5 Life Spine Inc. Recent Developments
11.17 Captiva Spine Inc.
11.17.1 Captiva Spine Inc. Company Details
11.17.2 Captiva Spine Inc. Business Overview
11.17.3 Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.17.4 Captiva Spine Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.17.5 Captiva Spine Inc. Recent Developments
11.18 CoreLink Surgical LLC
11.18.1 CoreLink Surgical LLC Company Details
11.18.2 CoreLink Surgical LLC Business Overview
11.18.3 CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.18.4 CoreLink Surgical LLC Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.18.5 CoreLink Surgical LLC Recent Developments
11.19 CTL Medical Corporation
11.19.1 CTL Medical Corporation Company Details
11.19.2 CTL Medical Corporation Business Overview
11.19.3 CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.19.4 CTL Medical Corporation Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.19.5 CTL Medical Corporation Recent Developments
11.20 Providence Medical Technology Inc.
11.20.1 Providence Medical Technology Inc. Company Details
11.20.2 Providence Medical Technology Inc. Business Overview
11.20.3 Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.20.4 Providence Medical Technology Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.20.5 Providence Medical Technology Inc. Recent Developments
11.21 Safe Orthopaedics
11.21.1 Safe Orthopaedics Company Details
11.21.2 Safe Orthopaedics Business Overview
11.21.3 Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.21.4 Safe Orthopaedics Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.21.5 Safe Orthopaedics Recent Developments
11.22 Spinal Elements Holdings Inc.
11.22.1 Spinal Elements Holdings Inc. Company Details
11.22.2 Spinal Elements Holdings Inc. Business Overview
11.22.3 Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.22.4 Spinal Elements Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.22.5 Spinal Elements Holdings Inc. Recent Developments
11.23 Spineology Inc.
11.23.1 Spineology Inc. Company Details
11.23.2 Spineology Inc. Business Overview
11.23.3 Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.23.4 Spineology Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.23.5 Spineology Inc. Recent Developments
11.24 Wenzel Spine Inc.
11.24.1 Wenzel Spine Inc. Company Details
11.24.2 Wenzel Spine Inc. Business Overview
11.24.3 Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.24.4 Wenzel Spine Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.24.5 Wenzel Spine Inc. Recent Developments
11.25 Xenco Medical.
11.25.1 Xenco Medical. Company Details
11.25.2 Xenco Medical. Business Overview
11.25.3 Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
11.25.4 Xenco Medical. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
11.25.5 Xenco Medical. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of XLIF Interbody Fusion Systems
Table 3. Key Players of XLIF Interbody Cages
Table 4. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Region (2018-2023)
Table 8. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Region (2024-2033)
Table 10. Extreme Lateral Interbody Fusion (XLIF) Surgery Market Trends
Table 11. Extreme Lateral Interbody Fusion (XLIF) Surgery Market Drivers
Table 12. Extreme Lateral Interbody Fusion (XLIF) Surgery Market Challenges
Table 13. Extreme Lateral Interbody Fusion (XLIF) Surgery Market Restraints
Table 14. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Share by Players (2018-2023)
Table 16. Global Top Extreme Lateral Interbody Fusion (XLIF) Surgery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery as of 2022)
Table 17. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Extreme Lateral Interbody Fusion (XLIF) Surgery, Headquarters and Area Served
Table 20. Global Key Players of Extreme Lateral Interbody Fusion (XLIF) Surgery, Product and Application
Table 21. Global Key Players of Extreme Lateral Interbody Fusion (XLIF) Surgery, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Type (2018-2023)
Table 25. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Type (2024-2033)
Table 27. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Share by Application (2018-2023)
Table 29. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Share by Application (2024-2033)
Table 31. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Country (2024-2033) & (US$ Million)
Table 63. Medtronic Plc Company Details
Table 64. Medtronic Plc Business Overview
Table 65. Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 66. Medtronic Plc Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 67. Medtronic Plc Recent Developments
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 71. Johnson & Johnson Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 72. Johnson & Johnson Recent Developments
Table 73. Stryker Corporation Company Details
Table 74. Stryker Corporation Business Overview
Table 75. Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 76. Stryker Corporation Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 77. Stryker Corporation Recent Developments
Table 78. Zimmer Biomet Holdings Inc. Company Details
Table 79. Zimmer Biomet Holdings Inc. Business Overview
Table 80. Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 81. Zimmer Biomet Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 82. Zimmer Biomet Holdings Inc. Recent Developments
Table 83. NuVasive Inc. Company Details
Table 84. NuVasive Inc. Business Overview
Table 85. NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 86. NuVasive Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 87. NuVasive Inc. Recent Developments
Table 88. Globus Medical Inc. Company Details
Table 89. Globus Medical Inc. Business Overview
Table 90. Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 91. Globus Medical Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 92. Globus Medical Inc. Recent Developments
Table 93. DePuy Synthes Company Details
Table 94. DePuy Synthes Business Overview
Table 95. DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 96. DePuy Synthes Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 97. DePuy Synthes Recent Developments
Table 98. B. Braun Melsungen AG Company Details
Table 99. B. Braun Melsungen AG Business Overview
Table 100. B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 101. B. Braun Melsungen AG Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 102. B. Braun Melsungen AG Recent Developments
Table 103. Alphatec Holdings Inc. Company Details
Table 104. Alphatec Holdings Inc. Business Overview
Table 105. Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 106. Alphatec Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 107. Alphatec Holdings Inc. Recent Developments
Table 108. RTI Surgical Holdings Inc. Company Details
Table 109. RTI Surgical Holdings Inc. Business Overview
Table 110. RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 111. RTI Surgical Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 112. RTI Surgical Holdings Inc. Recent Developments
Table 113. K2M Group Holdings Inc. Company Details
Table 114. K2M Group Holdings Inc. Business Overview
Table 115. K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 116. K2M Group Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 117. K2M Group Holdings Inc. Recent Developments
Table 118. Orthofix Medical Inc. Company Details
Table 119. Orthofix Medical Inc. Business Overview
Table 120. Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 121. Orthofix Medical Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 122. Orthofix Medical Inc. Recent Developments
Table 123. Aesculap Implant Systems Company Details
Table 124. Aesculap Implant Systems Business Overview
Table 125. Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 126. Aesculap Implant Systems Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 127. Aesculap Implant Systems Recent Developments
Table 128. SpineWave Inc. Company Details
Table 129. SpineWave Inc. Business Overview
Table 130. SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 131. SpineWave Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 132. SpineWave Inc. Recent Developments
Table 133. MicroPort Scientific Corporation Company Details
Table 134. MicroPort Scientific Corporation Business Overview
Table 135. MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 136. MicroPort Scientific Corporation Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 137. MicroPort Scientific Corporation Recent Developments
Table 138. Life Spine Inc. Company Details
Table 139. Life Spine Inc. Business Overview
Table 140. Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 141. Life Spine Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 142. Life Spine Inc. Recent Developments
Table 143. Captiva Spine Inc. Company Details
Table 144. Captiva Spine Inc. Business Overview
Table 145. Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 146. Captiva Spine Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 147. Captiva Spine Inc. Recent Developments
Table 148. CoreLink Surgical LLC Company Details
Table 149. CoreLink Surgical LLC Business Overview
Table 150. CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 151. CoreLink Surgical LLC Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 152. CoreLink Surgical LLC Recent Developments
Table 153. CTL Medical Corporation Company Details
Table 154. CTL Medical Corporation Business Overview
Table 155. CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 156. CTL Medical Corporation Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 157. CTL Medical Corporation Recent Developments
Table 158. Providence Medical Technology Inc. Company Details
Table 159. Providence Medical Technology Inc. Business Overview
Table 160. Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 161. Providence Medical Technology Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 162. Providence Medical Technology Inc. Recent Developments
Table 163. Safe Orthopaedics Company Details
Table 164. Safe Orthopaedics Business Overview
Table 165. Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 166. Safe Orthopaedics Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 167. Safe Orthopaedics Recent Developments
Table 168. Spinal Elements Holdings Inc. Company Details
Table 169. Spinal Elements Holdings Inc. Business Overview
Table 170. Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 171. Spinal Elements Holdings Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 172. Spinal Elements Holdings Inc. Recent Developments
Table 173. Spineology Inc. Company Details
Table 174. Spineology Inc. Business Overview
Table 175. Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 176. Spineology Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 177. Spineology Inc. Recent Developments
Table 178. Wenzel Spine Inc. Company Details
Table 179. Wenzel Spine Inc. Business Overview
Table 180. Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 181. Wenzel Spine Inc. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 182. Wenzel Spine Inc. Recent Developments
Table 183. Xenco Medical. Company Details
Table 184. Xenco Medical. Business Overview
Table 185. Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Product
Table 186. Xenco Medical. Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023) & (US$ Million)
Table 187. Xenco Medical. Recent Developments
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Type: 2022 VS 2033
Figure 3. XLIF Interbody Fusion Systems Features
Figure 4. XLIF Interbody Cages Features
Figure 5. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Application: 2022 VS 2033
Figure 7. Spinal Surgery Centers Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Others Case Studies
Figure 10. Extreme Lateral Interbody Fusion (XLIF) Surgery Report Years Considered
Figure 11. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Region: 2022 VS 2033
Figure 14. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Players in 2022
Figure 15. Global Top Extreme Lateral Interbody Fusion (XLIF) Surgery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extreme Lateral Interbody Fusion (XLIF) Surgery as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in 2022
Figure 17. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Type (2018-2033)
Figure 19. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Application (2018-2033)
Figure 20. North America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Country (2018-2033)
Figure 21. United States Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Type (2018-2033)
Figure 25. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Application (2018-2033)
Figure 26. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Country (2018-2033)
Figure 27. Germany Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Type (2018-2033)
Figure 35. China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Application (2018-2033)
Figure 36. Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Type (2018-2033)
Figure 38. Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Application (2018-2033)
Figure 39. Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Region (2018-2033)
Figure 40. Japan Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Extreme Lateral Interbody Fusion (XLIF) Surgery Market Share by Country (2018-2033)
Figure 50. Brazil Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Medtronic Plc Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 57. Johnson & Johnson Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 58. Stryker Corporation Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 59. Zimmer Biomet Holdings Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 60. NuVasive Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 61. Globus Medical Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 62. DePuy Synthes Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 63. B. Braun Melsungen AG Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 64. Alphatec Holdings Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 65. RTI Surgical Holdings Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 66. K2M Group Holdings Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 67. Orthofix Medical Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 68. Aesculap Implant Systems Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 69. SpineWave Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 70. MicroPort Scientific Corporation Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 71. Life Spine Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 72. Captiva Spine Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 73. CoreLink Surgical LLC Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 74. CTL Medical Corporation Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 75. Providence Medical Technology Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 76. Safe Orthopaedics Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 77. Spinal Elements Holdings Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 78. Spineology Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 79. Wenzel Spine Inc. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 80. Xenco Medical. Revenue Growth Rate in Extreme Lateral Interbody Fusion (XLIF) Surgery Business (2018-2023)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries